Table 1.
Characteristics | Total (n = 210) |
Survivor (n = 157) |
Non-Survivor (n = 53) |
p-Value |
---|---|---|---|---|
Sex (male) | 129 (61.4) | 98 (62.4) | 31 (58.5) | 0.730 |
Age (years) | 66.5 ± 18 | 63.7 ± 16.5 | 62.5 ± 14.1 | 0.637 |
HOD (days) | 55.8 ± 74.9 | 58.6 ± 83.2 | 47.6 ± 41.2 | 0.357 |
Charlson comorbidity index | 3.3 ± 2.1 | 3.2 ± 2.2 | 3.5 ± 2.1 | 0.419 |
SAPS II | 47.7 ± 21.3 | 43.5 ± 20.2 | 59.9 ± 19.8 | <0.001 |
Underlying disease, yes | ||||
MI | 25 (11.9) | 17 (10.8) | 8 (15.1) | 0.409 |
CHF | 30 (14.3) | 22 (14.0) | 8 (15.1) | 0.846 |
PAOD | 9(4.3) | 7 (4.5) | 2 (3.8) | 0.831 |
Cerebrovascular attack | 47 (22.4) | 39 (24.8) | 8 (15.1) | 0.141 |
Dementia | 10 (4.8) | 8 (5.1) | 2 (3.8) | 0.696 |
Chronic pulmonary disease | 43 (20.5) | 34 (21.7) | 9 (17.0) | 0.466 |
Connective tissue disease | 7 (3.3) | 5 (3.2) | 2 (3.8) | 0.836 |
Liver disease | 21 (10.0) | 14 (8.9) | 7 (13.2) | 0.427 |
Diabetes mellitus | 41 (19.5) | 32 (20.4) | 9 (17.0) | 0.589 |
Hemiplegia | 14 (6.7) | 13 (8.3) | 1 (1.9) | 0.198 |
CKD | 41 (19.5) | 30 (19.1) | 11 (20.8) | 0.794 |
ESRD | 28 (13.3) | 21 (13.5) | 7(13.2) | 0.963 |
Malignancy | 100 (47.6) | 73 (46.5) | 27 (50.9) | 0.634 |
Transplantation | ||||
SOT | 17 (8.1) | 12 (7.6) | 5 (9.4) | 0.771 |
PBSCT | 8 (3.8) | 6 (3.8) | 2 (3.8) | >0.999 |
Polymicrobial infection | 97 (46.2) | 80 (51.0) | 17 (32.1) | 0.017 |
Source of infection | 0.304 | |||
Pneumonia | 186 (88.6) | 137 (87.3) | 49 (92.5) | |
Primary bacteremia | 24 (11.4) | 20 (12.7) | 4 (7.5) |
HOD, hospital days of acquisition; SAPS II, simplified acute physiology score II; MI, myocardial infarction; CHF, congestive heart failure; PAOD, peripheral artery occlusive disease; CKD, chronic kidney disease; ESRD, end stage renal disease; SOT, Solid organ transplantation; PBSCT, Peripheral blood stem cell transplantation. Continuous variables are shown as the mean ± standard deviation (SD) and categorical variables, as numbers (percentage).